Correlation Between Mineralys Therapeutics, and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and AN2 Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and AN2 Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and AN2 Therapeutics
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Mineralys and AN2 is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and AN2 Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.6 times more return on investment than AN2 Therapeutics. However, Mineralys Therapeutics, Common is 1.66 times less risky than AN2 Therapeutics. It trades about 0.01 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 1,600 in Mineralys Therapeutics, Common on August 27, 2024 and sell it today you would lose (351.00) from holding Mineralys Therapeutics, Common or give up 21.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 91.13% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. AN2 Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| AN2 Therapeutics |
Mineralys Therapeutics, and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and AN2 Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges |